Diagnostic and prognostic biomarkers in cholangiocarcinoma
Rocı́o I.R. Macı́as(Universidad de Salamanca), Jesús M. Bañales(University of the Basque Country), Sabine Urban(University of Zurich), Nuno A. Paiva(University of the Basque Country), Miroslaw Kornek(University of Bonn), Pedro M. Rodrigues(Ikerbasque), Rui E. Castro(University of Lisbon), Christian Rupp(Heidelberg University), Sven H. Loosen(Düsseldorf University Hospital), Stephen P. Pereira(The Royal Free Hospital), Massimiliano Cadamuro(University of Padua), Tom Luedde(Düsseldorf University Hospital)
Cited by 138
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k